LSTM Group

We provide as PMP Innovation- and New Business Development Experts (NBDE) Future Business in Technology Scouting, Research Advanced Functional Materials, Functional Silane Hybrid Polymer Resin and Latent Nano Technology, PMP/PMO Professional Project Management, R&D-Service and Sustainable Technology to support your excellent Future Innovation Business Demands in

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

THERORNA COMPLETES SERIES A FINANCING TO ACCELERATE PIPELINE DEVELOPMENT AND CLINICAL TRANSFORMATION OF CIRCRNA-BASED PLATFORM

Therorna Inc. | June 21, 2022

news image

Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round. The round was co-led by a well-known industrial investment firm and MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital, demonstrating their continuous commitment to supporting Therorna'...

Read More

RESEARCH

STALLERGENES GREER AND APTAR PHARMA ANNOUNCE PARTNERSHIP TO DEVELOP NOVEL CONNECTED DEVICE FOR ALLERGEN IMMUNOTHERAPY TREATMENT DELIVERY

STALLERGENES GREER LTD | October 27, 2021

news image

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, for the development of the first of its kind connected device and companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. “This exclusive partn...

Read More

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

news image

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More

ALZECURE PHARMA PROVIDES A SCIENTIFIC UPDATE ON ALZHEIMER'S DISEASE AND THE ALZSTATIN PROJECT PLATFORM

AlzeCure Pharma | September 28, 2020

news image

CEO Martin Jönsson and CSO Johan Sandin will, among other things, present the pharmaceutical platform Alzstatin and the research behind it. Within the Alzstatin platform, AlzeCure develops disease-modifying and preventive drugs for Alzheimer's disease that focus on reducing the production of toxic amyloid beta (Aβ) in the brain. Henrik Zetterberg, chief physician and professor at the Department of Neuroscience and Physiology at Sahlgrenska Academy and professor at University Colleg...

Read More
news image

PHARMA TECH

THERORNA COMPLETES SERIES A FINANCING TO ACCELERATE PIPELINE DEVELOPMENT AND CLINICAL TRANSFORMATION OF CIRCRNA-BASED PLATFORM

Therorna Inc. | June 21, 2022

Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round. The round was co-led by a well-known industrial investment firm and MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital, demonstrating their continuous commitment to supporting Therorna'...

Read More
news image

RESEARCH

STALLERGENES GREER AND APTAR PHARMA ANNOUNCE PARTNERSHIP TO DEVELOP NOVEL CONNECTED DEVICE FOR ALLERGEN IMMUNOTHERAPY TREATMENT DELIVERY

STALLERGENES GREER LTD | October 27, 2021

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, for the development of the first of its kind connected device and companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. “This exclusive partn...

Read More
news image

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More
news image

ALZECURE PHARMA PROVIDES A SCIENTIFIC UPDATE ON ALZHEIMER'S DISEASE AND THE ALZSTATIN PROJECT PLATFORM

AlzeCure Pharma | September 28, 2020

CEO Martin Jönsson and CSO Johan Sandin will, among other things, present the pharmaceutical platform Alzstatin and the research behind it. Within the Alzstatin platform, AlzeCure develops disease-modifying and preventive drugs for Alzheimer's disease that focus on reducing the production of toxic amyloid beta (Aβ) in the brain. Henrik Zetterberg, chief physician and professor at the Department of Neuroscience and Physiology at Sahlgrenska Academy and professor at University Colleg...

Read More